EUVIMEDSkopri EUVIMED
Crossref

Protective Effect of Red Yeast Rice on Immune Checkpoint Inhibitors‐Related Atherosclerotic Progression Through Inhibiting Macrophage Inflammatory Response and T Lymphocytes Infiltration

Jian'an Pan iD, Hui Zhang, Xiaozhen He, Jian Zhang, Xuejun Wang, Yerui Zhang, Yuan Liu, Hao Lu iD, Leilei Cheng

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70261 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Jian'an Pan and 8 co-authors. Institution: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China. Major MEDLINE topics: Immune Checkpoint Inhibitors, Atherosclerosis, Macrophages, T-Lymphocytes. 53 references. Funded by: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Shanghai Shenkang Hospital Development Center municipal hospital diagnosis and treatment technology project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Immune checkpoint inhibitors (ICIs) have prolonged cancer survival but exacerbated atherosclerotic cardiovascular disease (ASCVD). This research aims to interrogate the underlying mechanism of ICIs‐related atherosclerotic progression and the potential protective effect of Red Yeast Rice (RYR) on it. A tumor‐bearing atherosclerotic (TB‐AS) mouse model was established by subcutaneously injecting MC38 cells in male ApoE −/− mice fed a high‐fat diet (HFD). Intraperitoneal anti‐PD‐1 antibody (αPD‐1) with/without dietary RYR supplementation was administered during the model. Serum was separated for lipid and inflammation evaluation. Plaque assessment was quantified by histological staining. Bone marrow‐derived macrophages (BMDMs) were isolated, incubated in growth medium containing 5% serum from the mice model, and treated with ox‐LDL and RYR. Cell viability was accessed by CCK8 assay. Lipid staining was employed to assess lipid droplet accumulation. The apoptosis and polarization of BMDMs were analyzed using flow cytometry. Cytokine levels were determined by luminex multiplex assay. And finally, western blot was conducted for mechanism investigation. αPD‐1 significantly increased atherosclerotic lesion area, plaque lipid content, and macrophage/T‐cell infiltration versus untreated TB‐AS controls. These effects coincided with elevated pro‐inflammatory cytokines/chemokines and reduced anti‐inflammatory mediators. RYR co‐treatment attenuated these αPD‐1‐induced pro‐atherogenic changes. In vitro, compared with serum from TB‐AS mice, BMDMs cultured with serum from αPD‐1‐treated TB‐AS mice exhibited reduced cell viability, elevated pro‐inflammatory cytokine levels in culture supernatants, enhanced M1 polarization, and increased apoptosis levels. All these phenotypic changes were reversed by RYR treatment. Mechanistically, RYR significantly inhibited the RhoA‐mediated activation of NF‐κB and MAPK signaling, thereby suppressing the αPD‐1‐induced inflammatory response in BMDMs. αPD‐1 promotes ASCVD progression by enhancing macrophage inflammation and T‐cell recruitment within plaques. RYR mitigates these effects through RhoA inhibition, suggesting its therapeutic potential for improving cardiovascular outcomes in ICIs‐treated cancer patients with ASCVD.

Subjects

MeSH terms (MEDLINE)

Immune Checkpoint InhibitorsAtherosclerosisMacrophagesT-LymphocytesBiological ProductsAnimalsMaleMiceInflammationApoptosisMice, Inbred C57BLDiet, High-FatDisease Models, AnimalPlaque, AtheroscleroticCytokinesMice, Knockout, ApoEApolipoproteins E

Author keywords

RhoAT‐cellatherosclerosisimmune checkpoint inhibitorsmacrophage

Substances

Immune Checkpoint Inhibitorsred yeast riceBiological ProductsCytokinesApolipoproteins E

Authors and institutions

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
  • Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
  • State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID profiles: Jian'an Pan, Hao Lu

Funding

  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Shanghai Shenkang Hospital Development Center municipal hospital diagnosis and treatment technology project
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • China Postdoctoral Science Foundation

Cite

APA

Pan, J., Zhang, H., He, X., Zhang, J., Wang, X., Zhang, Y., Liu, Y., Lu, H., & Cheng, L. (2026). Protective Effect of Red Yeast Rice on Immune Checkpoint Inhibitors‐Related Atherosclerotic Progression Through Inhibiting Macrophage Inflammatory Response and T Lymphocytes Infiltration. Phytotherapy Research. https://doi.org/10.1002/ptr.70261

Vancouver

Pan J, Zhang H, He X, Zhang J, Wang X, Zhang Y, et al. Protective Effect of Red Yeast Rice on Immune Checkpoint Inhibitors‐Related Atherosclerotic Progression Through Inhibiting Macrophage Inflammatory Response and T Lymphocytes Infiltration. Phytotherapy Research. 2026. doi:10.1002/ptr.70261

BibTeX
@article{Pan2026,
  author = {Pan, Jian'an and Zhang, Hui and He, Xiaozhen and Zhang, Jian and Wang, Xuejun and Zhang, Yerui and Liu, Yuan and Lu, Hao and Cheng, Leilei},
  title = {Protective Effect of Red Yeast Rice on Immune Checkpoint Inhibitors‐Related Atherosclerotic Progression Through Inhibiting Macrophage Inflammatory Response and T Lymphocytes Infiltration},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70261}
}
Start for free →